Loading...
•
Mar 31, 2021
Chemed Q1 2021 Earnings Report
Chemed's financial performance in Q1 2021 was reported, featuring revenue growth and increased EPS, alongside segment-specific results for VITAS and Roto-Rooter.
Key Takeaways
Chemed Corporation reported a 2.2% increase in revenue to $527 million for Q1 2021. GAAP Diluted EPS increased by 18.6% to $4.01, and Adjusted Diluted EPS rose by 20.7% to $4.44. The VITAS segment experienced a revenue decline, while Roto-Rooter saw significant revenue growth.
Chemed's revenue increased by 2.2% to $527 million.
GAAP Diluted EPS increased by 18.6% to $4.01.
Roto-Rooter's revenue increased by 18.9% to $212 million.
VITAS Healthcare's net patient revenue decreased by 6.5% to $316 million.
Chemed
Chemed
Chemed Revenue by Segment
Chemed Revenue by Geographic Location
Revenue by Segment
VITAS Revenue
CapyFin.comRoto-Rooter Revenue
CapyFin.comRevenue by Geographic Location
United States Revenue
CapyFin.com Forward Guidance
Management anticipates providing updated 2021 earnings guidance in July 2021 as part of the June 30, 2021, earnings press release.
Revenue & Expenses
Visualization of income flow from segment revenue to net income